Skip to main content
SpringerLink
Log in

Choosing the form of nicotine replacement therapy (NRT) based on the individual smoker’s needs and preferences may improve abstinence rates

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. McClure JB, Swan GE. Tailoring nicotine replacement therapy: rationale and potential approaches. CNS Drugs 2006; 20(4): 281–91

    Article  PubMed  CAS  Google Scholar 

  2. Balfour DJ. The neurobiology of tobacco dependence: a preclinical perspective on the role of the dopamine projections to the nucleus accumbens [corrected]. Nicotine Tob Res 2004; 6(6): 899–912

    Article  PubMed  CAS  Google Scholar 

  3. Keating GM, Siddiqui MAA. Varenicline: a review of its use as an aid to smoking cessation therapy. CNS Drugs 2006; 20(11): 945–60

    Article  PubMed  CAS  Google Scholar 

  4. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guidelines. Rockville (MD): United States Department of Health and Human Services, Public Health Service, 2000

    Google Scholar 

  5. Curry SJ, Ludman EJ, McClure J. Self-administered treatment for smoking cessation. J Clin Psychol 2003; 59(3): 305–19

    Article  PubMed  Google Scholar 

  6. Hays JT, Ebbert JO. Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. CNS Drugs 2003; 17(2): 71–83

    Article  PubMed  CAS  Google Scholar 

  7. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006 Jul 5; 296(1): 56–63

    Article  PubMed  CAS  Google Scholar 

  8. Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; (3): CD000146

  9. Henningfield JE, Fant RV, Buchhalter AR, et al. Pharmacotherapy for nicotine dependence. CA Cancer J Clin 2005; 55: 281–99

    Article  PubMed  Google Scholar 

  10. British national formulary. No. 51. London: The Pharmaceutical Press, 2006 Mar

  11. Haustein KO. What can we do in secondary prevention of cigarette smoking? Eur J Cardiovasc Prev Rehabil 2003; 10(6): 476–85

    Article  PubMed  Google Scholar 

  12. West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 2000; 55: 987–99

    Article  PubMed  CAS  Google Scholar 

  13. Medioni J, Berlin I, Mallet A. Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach. Addiction 2005; 100(2): 247–54

    Article  PubMed  Google Scholar 

  14. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340: 685–91

    Article  PubMed  CAS  Google Scholar 

  15. Killen JD, Robinson TN, Ammerman S, et al. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol 2004; 72: 729–35

    Article  PubMed  Google Scholar 

  16. Joseph AM, Norman SM, Ferry LH, et al. The safety of trans-dermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335: 1792–8

    Article  PubMed  CAS  Google Scholar 

  17. Ludvig J, Miner B, Eisenberg MJ. Smoking cessation in patients with coronary artery disease. Am Heart J 2005; 149: 565–72

    Article  PubMed  Google Scholar 

  18. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Saf 2001; 24: 277–322

    Article  PubMed  CAS  Google Scholar 

  19. Coleman T, Antoniak M, Britton J, et al. Recruiting pregnant smokers for a placebo-randomised controlled trial of nicotine replacement therapy. BMC Health Serv Res 2004; 4: 29

    Article  PubMed  Google Scholar 

  20. Moolchan ET, Robinson ML, Ernst M, et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics 2005; 115: E407–14

    Article  PubMed  Google Scholar 

  21. Abrams DB, Niaura R, Brown RA, et al. The tobacco dependence treatment handbook: a guide to best practices. New York: The Guilford Press, 2003

    Google Scholar 

  22. American Psychiatric Association. Practice guideline for the treatment of patients with nicotine dependence. Am J Psychiatry 1996; 153: 1–31

    Google Scholar 

  23. Johnstone EC, Yudkin PL, Hey K, et al. Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics 2004; 14: 83–90

    Article  PubMed  CAS  Google Scholar 

  24. Lerman C, Wileyto EP, Patterson F, et al. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J 2004; 4: 184–92

    Article  PubMed  CAS  Google Scholar 

  25. Lerman C, Jepson C, Wileyto EP, et al. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuro-psychopharmacology 2006; 31: 231–42

    CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Choosing the form of nicotine replacement therapy (NRT) based on the individual smoker’s needs and preferences may improve abstinence rates. Drugs Ther. Perspect 22, 15–18 (2006). https://doi.org/10.2165/00042310-200622120-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200622120-00005

Search

Navigation